NTRA
Natera IncNASDAQHEALTHCAREDIAGNOSTICS & RESEARCH
Key Statistics
Market Cap
$30.21B
P/E Ratio
—
EPS
$-1.54
Beta
1.57
52W High
$256.36
52W Low
$131.81
50-Day MA
$201.99
200-Day MA
$197.13
Dividend Yield
—
Profit Margin
-9.03%
Forward P/E
—
PEG Ratio
0.00
About Natera Inc
Natera, Inc., a diagnostic company, develops and markets molecular testing services globally. The company is headquartered in San Carlos, California.
Fundamentals
| Revenue (TTM) | $2.31B |
| Gross Profit (TTM) | $1.49B |
| EBITDA | $-271.43M |
| Operating Margin | -3.42% |
| Return on Equity | -14.30% |
| Return on Assets | -9.54% |
| Revenue/Share (TTM) | $16.87 |
| Book Value | $12.26 |
| Price-to-Book | 17.28 |
| Price-to-Sales (TTM) | 13.10 |
| EV/Revenue | 12.46 |
| EV/EBITDA | -26.80 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 39.80% |
| Shares Outstanding | $142.78M |
| Float | $137.43M |
| % Insiders | 3.08% |
| % Institutions | 94.31% |
Historical Volatility
HV 10-Day
42.11%
HV 20-Day
57.03%
HV 30-Day
56.89%
HV 60-Day
48.82%
HV Rank
91.3%
Volatility is currently contracting
Analyst Ratings
Consensus ($258.00 target)
5
Strong Buy12
Buy2
HoldMore HEALTHCARE Stocks
Data last updated: 5/5/2026